Wei-Dong Yin

InstitutionUniversity of South China
AddressChina
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in May 2020 and November 2020 and February 2021
    All Publications
    Bar chart showing 87 publications over 20 distinct years, with a maximum of 9 publications in 2009 and 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 06; 21(6):803-812. PMID: 33548194.
      Citations: 94     Fields:    Translation:HumansPHPublic Health
    2. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192. PMID: 33217362.
      Citations: 278     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    3. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81. PMID: 32376603.
      Citations: 457     Fields:    Translation:AnimalsCellsPHPublic Health
    4. Yin W. ?Fighting against infectious diseases in China. Hum Vaccin. 2011 Dec; 7(12):1250-3. PMID: 22185808.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    5. Lin JT, Zhang JS, Su N, Xu JG, Wang N, Chen JT, Chen X, Liu YX, Gao H, Jia YP, Liu Y, Sun RH, Wang X, Yu DZ, Hai R, Gao Q, Ning Y, Wang HX, Li MC, Kan B, Dong GM, An Q, Wang YQ, Han J, Qin C, Yin WD, Dongs XP. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antivir Ther. 2007; 12(7):1107-13. PMID: 18018769.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    6. Zhang JS, Chen JT, Liu YX, Zhang ZS, Gao H, Liu Y, Wang X, Ning Y, Liu YF, Gao Q, Xu JG, Qin C, Dong XP, Yin WD. A serological survey on neutralizing antibody titer of SARS convalescent sera. J Med Virol. 2005 Oct; 77(2):147-50. PMID: 16121363.
      Citations: 41     Fields:    Translation:HumansCells
    7. Zhang J, Liu Y, Hu L, Gao Q, Zhang Z, Zhang X, Chen J, Gong X, Song L, Liu Y, Li J, Li J, Li S, Huang J, Ning Y, Gao H, Qin C, Dong X, Wei J, Dong G, Yin W. Preparation and characterization of SARS in-house reference antiserum. Vaccine. 2005 Dec 01; 23(48-49):5666-9. PMID: 16269206.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    8. Xie SY, Zeng G, Chen JT, Liu YX, Li SF, Yin WD. [Serological investigation on close contacts to patients with severe acute respiratory syndrome in an SARS outbreak]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Oct; 25(10):867-9. PMID: 15631743.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health